Adult group in immunogenicity and safety study of combined immunization
PRO-nCOV-MA4005-BJ
Approved mab completed
Quick answer
Adult group in immunogenicity and safety study of combined immunization for COVID-19 is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- COVID-19
- Phase
- Approved
- Modality
- mab
- Status
- completed